Northrop Grumman projects $44B 2026 sales midpoint as it raises EPS guide to $28.60-$29.10 (NYSE:NOC)

Northrop Grumman (NOC) delivered a substantive positive earnings signal by raising full-year 2026 guidance across both top-line revenue and bottom-line earnings per share. The $44B sales midpoint and $28.60–$29.10 EPS range represent management confidence in demand sustainability and operational execution through a challenging macro environment.

The $105B record backlog is a critical inflection point, signaling multi-year revenue visibility and strong order intake momentum. This backlog depth insulates the company from near-term volatility and validates elevated capital deployment by defense procurement agencies, particularly in advanced aerospace, missiles, and space systems where geopolitical tensions continue driving budget priorities.

Program-level risks flagged on the earnings call warrant monitoring—execution risk on large contracts and supply-chain dependencies remain structural headwinds. However, the magnitude of guidance raises suggests management has priced these risks adequately and expects margin expansion or favorable mix shifts in 2026.

Sector implication: This move reinforces cyclical strength in the Industrials sector, particularly defense contractors. NOC's bullish revision likely supports peer sentiment (LMT, RTX, GD) and signals investor appetite for secular tailwinds in U.S. military modernization spending, space-based systems, and allied defense commitments.